{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "4-Nitroquinoline 1-oxide",
      "Mouse",
      "Oral cancer",
      "Oral carcinogenesis",
      "Oral leukoplakia"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33785166",
  "DateCompleted": {
    "Year": "2021",
    "Month": "11",
    "Day": "25"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "11",
    "Day": "25"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "11",
        "Day": "12"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/bs.mcb.2020.09.004",
      "S0091-679X(20)30178-3"
    ],
    "Journal": {
      "ISSN": "0091-679X",
      "JournalIssue": {
        "Volume": "163",
        "PubDate": {
          "Year": "2021"
        }
      },
      "Title": "Methods in cell biology",
      "ISOAbbreviation": "Methods Cell Biol"
    },
    "ArticleTitle": "The 4-NQO mouse model: An update on a well-established in vivo model of oral carcinogenesis.",
    "Pagination": {
      "StartPage": "197",
      "EndPage": "229",
      "MedlinePgn": "197-229"
    },
    "Abstract": {
      "AbstractText": [
        "The early detection and management of oral premalignant lesions (OPMDs) improve their outcomes. Animal models that mimic histological and biological processes of human oral carcinogenesis may help to improve the identification of OPMD at-risk of progression into oral squamous cell carcinoma and to develop preventive strategies for the entire field of cancerization. No animal model is perfectly applicable for investigating human oral carcinogenesis. However, the 4-nitroquinoline 1-oxide (4-NQO) mouse model is well established and mimics several morphological, histological, genomic and molecular features of human oral carcinogenesis. Some of the reasons for the success of this model include its reproducible experimental conditions with limited variation, the possibility of realizing longitudinal studies with invasive intervention or gene manipulation, and sample availability for all stages of oral carcinogenesis, especially premalignant lesions. Moreover, the role of histological and molecular alterations in the field of cancerization (i.e., macroscopically healthy mucosa exposed to a carcinogen) during oral carcinogenesis can be easily explored using this model. In this review, we discuss the advantages and drawbacks of this model for studying human oral carcinogenesis. In summary, the 4-NQO-induced murine oral cancer model is relevant for investigating human oral carcinogenesis, including the immune microenvironment, and for evaluating therapeutic and chemoprevention agents."
      ],
      "CopyrightInformation": "Copyright \u00a9 2021 Elsevier Inc. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Univ Lyon, Universit\u00e9 Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre L\u00e9on B\u00e9rard, Centre de Recherche en Canc\u00e9rologie de Lyon, Lyon, France; Sorbonne Universit\u00e9, Department of Maxillo-Facial Surgery, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Assistance Publique des H\u00f4pitaux de Paris, Paris, France."
          }
        ],
        "LastName": "Bouaoud",
        "ForeName": "J",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Univ Lyon, Universit\u00e9 Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre L\u00e9on B\u00e9rard, Centre de Recherche en Canc\u00e9rologie de Lyon, Lyon, France."
          }
        ],
        "LastName": "De Souza",
        "ForeName": "G",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia."
          }
        ],
        "LastName": "Darido",
        "ForeName": "C",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pathology, VetAgro Sup, University of Lyon, Marcy-l'\u00c9toile, France."
          }
        ],
        "LastName": "Tortereau",
        "ForeName": "A",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "The Shraga Segal Department of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, Israel."
          }
        ],
        "LastName": "Elkabets",
        "ForeName": "M",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Sorbonne Universit\u00e9, Department of Maxillo-Facial Surgery, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Assistance Publique des H\u00f4pitaux de Paris, Paris, France."
          }
        ],
        "LastName": "Bertolus",
        "ForeName": "C",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Univ Lyon, Universit\u00e9 Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre L\u00e9on B\u00e9rard, Centre de Recherche en Canc\u00e9rologie de Lyon, Lyon, France; Department of Medical Oncology, Centre L\u00e9on B\u00e9rard, Lyon, France. Electronic address: pierre.saintigny@lyon.unicancer.fr."
          }
        ],
        "LastName": "Saintigny",
        "ForeName": "P",
        "Initials": "P"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Methods Cell Biol",
    "NlmUniqueID": "0373334",
    "ISSNLinking": "0091-679X"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Carcinogens"
    },
    {
      "RegistryNumber": "56-57-5",
      "NameOfSubstance": "4-Nitroquinoline-1-oxide"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "toxicity"
      ],
      "DescriptorName": "4-Nitroquinoline-1-oxide"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Carcinogenesis"
    },
    {
      "QualifierName": [
        "toxicity"
      ],
      "DescriptorName": "Carcinogens"
    },
    {
      "QualifierName": [
        "chemically induced",
        "genetics"
      ],
      "DescriptorName": "Carcinoma, Squamous Cell"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mice"
    },
    {
      "QualifierName": [
        "chemically induced"
      ],
      "DescriptorName": "Mouth Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Tumor Microenvironment"
    }
  ]
}